Precipio, Inc.

PRPO · Nasdaq · SIC 3826: Laboratory Analytical Instruments · Market Cap: $0.1B · 71 employees
402
SEC Filings
$22.8
Close 2026-05-29
71
Employees

Business Summary

Precipio, Inc. is a healthcare biotechnology company focused on improving cancer diagnostics, particularly hematologic malignancies. The company operates two divisions: a Pathology Services Division providing specialized cancer diagnostic testing (molecular diagnostics, cytogenetics) to physicians, hospitals, and laboratories; and a Products Division that develops and commercializes proprietary diagnostic assays and kits for use by other clinical laboratories. Its integrated R&D model uses clinical lab operations to develop and validate diagnostic products at incremental cost.

Latest Stock Quote

PRPO 2026-05-29 $22.8 O:$23.59 H:$24.21 L:$22.8 Vol:0.0M VWAP:$23.15
origin leaf: 3dbd4d04e9fcc247d84ed21e18ec2cc117bddbf3a50e66ebfa917a71e6651c88

Next Earnings

Q2 FY2026 — expected 2026-09-14

Annual Reports (10-K)

FiledPeriodAccessionSourceFull Text
2026-03-302025-12-310001104659-26-036878EDGAR63K words
2025-03-272024-12-310001558370-25-003817EDGAR
2024-03-292023-12-310001558370-24-004365EDGAR
2023-03-302022-12-310001558370-23-005076EDGAR
2022-03-302021-12-310001558370-22-004774EDGAR
2021-03-292020-12-310001558370-21-003619EDGAR
2020-03-272019-12-310001558370-20-003247EDGAR
2019-04-162018-12-310001558370-19-003039EDGAR
2018-04-132017-12-310001144204-18-020539EDGAR
2017-04-132016-12-310001043961-17-000005EDGAR

Quarterly Reports (10-Q)

FiledPeriodAccessionSourceFull Text
2025-11-142025-09-300001104659-25-112601EDGAR22K words
2025-08-132025-06-300001558370-25-011390EDGAR
2025-05-142025-03-310001558370-25-007776EDGAR
2024-11-062024-09-300001558370-24-014619EDGAR
2024-08-132024-06-300001558370-24-012053EDGAR
2024-05-142024-03-310001558370-24-008128EDGAR
2023-11-132023-09-300001558370-23-018820EDGAR
2023-08-112023-06-300001558370-23-014655EDGAR
2023-05-122023-03-310001558370-23-009597EDGAR
2022-11-102022-09-300001558370-22-017400EDGAR
2022-08-112022-06-300001558370-22-013260EDGAR
2022-05-112022-03-310001558370-22-008317EDGAR

Recent Current Reports (8-K)

FiledAccessionSourceFull Text
2026-02-270001104659-26-021625EDGAR1K words
2025-12-290001104659-25-124902EDGAR
2025-11-060001104659-25-107708EDGAR
2025-09-030001104659-25-086995EDGAR
2025-08-180001104659-25-079859EDGAR
2025-07-310001104659-25-072760EDGAR
2025-06-170001104659-25-060236EDGAR
2025-05-150001104659-25-049371EDGAR
2025-05-060001104659-25-045024EDGAR
2025-04-100001104659-25-033457EDGAR

402 total filings indexed. 370 additional filings (S-1, DEF 14A, etc.) View all (JSON) · SEC EDGAR

Sector Peers

TXG — 10x Genomics, Inc. A — AGILENT TECHNOLOGIES, INC. ASTC — ASTROTECH Corp AVTR — Avantor, Inc. BIO — BIO-RAD LABORATORIES, INC. BFNH — BIOFORCE NANOSCIENCES HOLDINGS, INC. BRKR — BRUKER CORP BNGO — Bionano Genomics, Inc.

Tags

oncology-diagnostics hematologic-malignancies clinical-laboratory-services healthcare-biotechnology u.s.-clinical-laboratory-improvement-act-of-1967 u.s.-clinical-laboratory-improvement-amendments-of-1988 european-union-in-vitro-diagnostics-regulation

Company Identity

CIK0001043961
TickerPRPO
ExchangeNasdaq
SIC3826: Laboratory Analytical Instruments
IncorporatedDE
Websitehttps://www.precipiodx.com
Listed2000-07-18

Get More Data

This is the free public profile. For structured JSON with full provenance chain, use the API:

JSON Profile Stock Quote AI Readiness Report
Origin Provenance
page leaf: 85f81c0d4ae200eacb0fbfc0f14c521fb5ad016193929bcf1baf5df148791188
parent: f1cdf2b99a69a021cd51e808793bd3465c6dad59e1844cab8337e44526a73abc
content hash: 73b020b51933a5c60839e66fe423db38d993ada6d9175dd3d210d2c0e7068cc0
signed: 2026-06-02T19:02:21.495Z
sources: 23 verified data leaves
chain: SEC.gov PEM → origin.rootz.global extraction → this page
verify: sha256(content_hash + parent + timestamp) = leaf